Another big-ticket IPO in the works. The Rs 3,395 crore Anthem Biosciences IPO will open next Monday. A book-built issue, it is a pure offer for sale with no fresh issue component. Anthem Biosciences, a CDMO play, has fully integrated operations encompassing drug discovery, development, and manufacturing processes.
Here is a quick look at the key IPO details:
Anthem Biosciences IPO: Issue launch date, size
The Anthem Biosciences IPO is a Rs 3,395 crore issue, and a total of 5.96 crore shares are on offer. The issue opens on July 14, and bidding will continue till July 16. A fully book-built issue, this is primarily an offer for sale. Promoters and key investors are going to offload stake via the IPO.
Anthem Biosciences IPO: Issue price band, lot size
The price band for Anthem Biosciences has been set at Rs 540 -570 per share. The lot size has been fixed at 26 per application. Retail investors need to invest a minimum of Rs 14,040, or 1 lot (the value of 26 shares). The lot size investment for NIIs is higher at 14 equalling 364 shares, and the total amount for this will be Rs 2,07,480, and for bNII, it is fixed at 68 lots, equalling a total of Rs 10,07,760.
Anthem Biosciences IPO: Objective
As there is no fresh issue, there won’t be any fresh funds generated. The company will not get any of the proceeds. As this is an offer for sale, the shareholders diluting their stake would get the money. However, offer-related expenses would be deducted, and shareholders would also have relevant tax deductions. Anthem Biosciences IPO: Promoter shareholding
The promoter shareholding after the IPO would be 74.68%. Before the IPO, their shareholding was 76.87%.
Anthem Biosciences IPO: Allotment, listing
The tentative allotment date for the Anthem Biosciences IPO has been fixed on July 17. Refunds will be initiated on July 18, and the issue is likely to list on July 21.
Anthem Biosciences IPO: Managers and registrars
The book running lead manager for the Anthem Biosciences IPO is JM Financial, and the registrar for the issue is Kfin Technologies.
